We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Vast Majority of Coronavirus Infections Go Undetected

By HospiMedica International staff writers
Posted on 20 Apr 2020
A new study suggests that only 6% of SARS-CoV-2 infections worldwide have been identified, and the actual number of infections is in the tens of millions.

Researchers at the University of Göttingen (Germany) used estimates of COVID-19 mortality and time until death from a recent study published in The Lancet Infectious Diseases (DOI: 10.1016/S1473-3099(20)30243-7) to test the quality of official case records issued by countries. More...
On the day of publication, April 8, 2020, the researchers estimated that in Germany alone there were 460,000 infections, instead of the 71,000 reported officially. Using the same estimation technique, the US would have about 10 million cases today, instead of the 533,000 reported, and Spain would have over five million, and not 180,000.

The researchers suggest that insufficient and delayed testing may explain why some European countries, such as Italy and Spain, are experiencing much higher casualty numbers (relative to reported confirmed cases) than Germany, which has detected an estimated 15.6% of infections, compared to only 3.5% in Italy or 1.7% in Spain. Detection rates are even lower in the United States (about 1.6%) and the United Kingdom (1.2%), two countries that have received widespread criticism from public health experts for their delayed response to the pandemic. In contrast, South Korea appears to have discovered almost half of all its SARS-CoV-2 infections.

Based on these methods, the researchers estimate an overall case fatality ratio of 1.4%, much lower than that of the past SARS and MERS epidemics, but still higher than the estimated case fatality ratio for the H1N1 flu epidemic in 2001. Case fatality ratio also varies with the type of patient assessed, such as severe symptomatic versus mild unreported cases. Moreover, in those aged less than 60 years, it is just 0.32%, compared to 6.4% in those aged 60 or more, to 13% in those who are 80 years old or more.

“These results mean that governments and policy-makers need to exercise extreme caution when interpreting case numbers for planning purposes,” said co-lead author professor of development economics Sebastian Vollmer, PhD. “Such extreme differences in the amount and quality of testing carried out in different countries mean that official case records are largely uninformative and do not provide helpful information.”

“Putting an end to current travel restrictions and social distancing measures will not only require a strong reduction in the transmission of new cases, but also major improvements in the ability of countries to detect new infections to then adopt adequate measures for isolating infected patients and tracing potential contact persons,” concluded Professor Vollmer. “In absence of such measures, the virus might remain undetected again for an extended period of time and a new outbreak is likely just a matter of time.”

Related Links:
University of Göttingen

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.